Senna Syrup
- Product NDC
- 54859-808
- 11-digit product format
- 548590808
- Labeler code
- 54859
- Product ID
- 54859-808_471f34fb-ff03-54f3-e063-6394a90afacc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sennosides
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Llorens Pharmaceutical International Division, Inc.
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2019-05-01
- Substance
- SENNOSIDES
- Active strength
- 8.8 mg/5mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Senna Syrup
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SENNOSIDES | 8.8 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3FYP5M0IJX | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 702311 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5be0163c-b7f7-46db-b738-78c2946a6cf6 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54859-808-08 | Senna Syrup | 237 mL in 1 BOTTLE | LIQUID | 237 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54859-808-08 | ML - Milliliter | 54859-808 | b7229fb6-73e6-4981-a025-f958cb6549ee | 1 | 2020-05-08 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Publix Fiber Therapy Sugar Free | PSYLLIUM HUSK | PUBLIX SUPER MARKETS, INC | ed3dc80a-a243-4013-9886-b148e3e3b662 | 2025-10-28 | Warnings | M007 |
| Childrens Oral Saline Laxative | MAGNESIUM HYDROXIDE | WAL-MART STORES,INC., | a2eb50ab-851a-4abb-a12f-6d9d8b0cb6bc | 2025-10-27 | Warnings | M007 |
| equate Fiber Therapy | METHYLCELLULOSE | Wal-Mart Stores,Inc., | 7acc30b4-e946-42cd-8eec-cf15159d478d | 2025-10-27 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97aa5b-62e2-0664-e053-2a91aa0ac341 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | H E B | 3d03ce42-e671-6d76-e054-00144ff8d46c | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | CVS Pharmacy | c56e010a-7503-3e1c-e053-2a95a90a2b85 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 022dd494-cb3c-4fa7-be99-4c38fabdc612 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97c4d2-e41d-5bb6-e053-2a91aa0a3163 | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Major Pharmaceuticals | c194c40c-c732-2f03-e053-2a95a90a7a40 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | CVS Pharmacy | 94e4a6f3-43d0-b2a5-e053-2a95a90aa115 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 5e83d3ef-91c5-1c3a-e053-2a91aa0a93ed | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f3bc-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Pharmacy Value Alliance LLC | 8a6d6729-f6eb-4f68-e053-2a95a90a5c9e | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f37a-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | a381838b-d1ae-11c5-e053-2a95a90a7bcb | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | 90a4d385-d548-420b-91d2-54d5e819fcce | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Cardinal Health | c2b33e78-6ab7-1785-e053-2995a90a9c4f | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | CVS Pharmacy | 3a59c4a9-5f86-406a-e054-00144ff8d46c | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Cardinal Health | 7e7e9366-af1e-e0ff-e053-2a91aa0a9487 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Cardinal Health | c2b02afc-5a8a-2a25-e053-2a95a90ae45c | 2025-10-24 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | 5be0163c-b7f7-46db-b738-78c2946a6cf6 | 6 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | 5be0163c-b7f7-46db-b738-78c2946a6cf6 | 6 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | 5be0163c-b7f7-46db-b738-78c2946a6cf6 | 6 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | 5be0163c-b7f7-46db-b738-78c2946a6cf6 | 6 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | 5be0163c-b7f7-46db-b738-78c2946a6cf6 | 6 |
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | e1dca0d6-6e6e-4ba2-a7b8-009aeb00ef63 | 4 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | e1dca0d6-6e6e-4ba2-a7b8-009aeb00ef63 | 4 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | e1dca0d6-6e6e-4ba2-a7b8-009aeb00ef63 | 4 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | e1dca0d6-6e6e-4ba2-a7b8-009aeb00ef63 | 4 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | e1dca0d6-6e6e-4ba2-a7b8-009aeb00ef63 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 54859-808-08 | 54859080808 | 237 mL in 1 BOTTLE (54859-808-08) | 237 ml | 2019-05-01 | 0000-00-00 | No | No | Current |